Thirty days after the surgery, the first xenogeneic kidney transplant patient in Asia shows stable kidney function and vital signs, meeting the discharge requirements at Xijing Hospital in Xi'an.

The hospital's medical team closely observed various indicators and dynamically adjusted treatment plans to address immune rejection, pathogen infection, and coagulation disorders. More than 20 departments have formed a joint diagnosis team to ensure postoperative recovery.

Qin Weijun, director of Urology at Xijing Hospital, stated that the team has established a system that integrates precise evaluation, real-time monitoring, and multidisciplinary linkage. Through continuous monitoring of the patient and the transplanted kidney, the team conducted timely intervention and dynamic regulation, providing the patient with a scientific, safe, and effective treatment plan.

"This research has provided new ideas for clinical treatment of patients with end-stage renal disease (ESRD), further confirming the possibility and effectiveness of xenotransplantation in clinical application and providing important theoretical basis and technical support for future clinical practice," said Dou Kefeng, academician of the Chinese Academy of Sciences.

About 150,000 new cases of ESRD patients are diagnosed in China every year, and less than 5 percent can obtain donors. This innovative technology is expected to change that and provide a better prognosis for those with chronic kidney disease.